S B Squire
Overview
Explore the profile of S B Squire including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
869
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Squire S, Taegtmeyer M, Javed Q, ODempsey T, Kullu C, Lepping P
Trans R Soc Trop Med Hyg
. 2024 Sep;
118(12):808-813.
PMID: 39227030
Background: Delusional infestation (DI) is a well-recognized delusional disorder presenting as the persisting belief of being infested. Combined clinics have been run by dermatology and psychiatry in a small number...
2.
Bimba J, Adekeye O, Iem V, Eliya T, Osagie I, Kontogianni K, et al.
Public Health Action
. 2023 May;
13(1):12-16.
PMID: 37152212
Background: The use of molecular amplification as-says for TB diagnosis is limited by their costs and cartridge stocks. Pooling multiple samples to test them together is reported to have similar...
3.
Tomeny E, Mendoza V, Marcelo D, Barrameda A, Langley I, Abong J, et al.
Int J Tuberc Lung Dis
. 2020 Apr;
24(4):420-427.
PMID: 32317067
Eight tuberculosis treatment sites in Cavite Province, the Philippines, including two sites specialising in management of multidrug-resistant tuberculosis (MDR-TB). To evaluate costs incurred by TB patients and to determine the...
4.
Wingfield T, Macpherson P, Sodha P, Tucker A, Mithoo J, Squire S, et al.
Int J Tuberc Lung Dis
. 2019 Mar;
23(3):337-343.
PMID: 30871665
Objective: To investigate the association between patients' social risk factors and the risk of tuberculous infection and TB disease among their contacts in England. Design: This was a cohort study...
5.
Bogdanova E, Mariandyshev A, Balantcev G, Eliseev P, Nikishova E, Gaida A, et al.
PLoS One
. 2019 Jan;
14(1):e0211203.
PMID: 30695043
Background: The development of new diagnostic tools allows for faster detection of both tuberculosis (TB) and multidrug-resistant (MDR) TB and should lead to reduced transmission by earlier initiation of anti...
6.
A systematic review of clinical outcomes on the WHO Category II retreatment regimen for tuberculosis
Cohen D, Meghji J, Squire S
Int J Tuberc Lung Dis
. 2018 Sep;
22(10):1127-1134.
PMID: 30236179
Objective: To assess the clinical outcomes of patients prescribed the World Health Organization (WHO) Category II retreatment regimen for tuberculosis (TB). Design: A systematic review of the literature was performed...
7.
Cohen D, Phiri M, Banda H, Squire S, Namakhoma I, Desmond N
BMC Public Health
. 2018 Sep;
18(1):1127.
PMID: 30223808
Background: Patients being treated for recurrent or multidrug-resistant tuberculosis (TB) require long courses of injectable anti-tuberculous agents. In order to maintain strong TB control programmes, it is vital that the...
8.
Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in Brazil
Ramalho D, Miranda P, Andrade M, Brigido T, Dalcolmo M, Mesquita E, et al.
BMC Infect Dis
. 2017 Aug;
17(1):571.
PMID: 28810911
Background: The implementation of rapid drug susceptibility testing (DST) is a current global priority for TB control. However, data are scarce on patient-relevant outcomes for presumptive diagnosis of drug-resistant tuberculosis...
9.
Squire S, Thomson R, Namakhoma I, El Sony A, Kritski A, Madan J
BMC Proc
. 2017 Mar;
9(Suppl 10):S4.
PMID: 28281702
Costs incurred during care-seeking for chronic respiratory disease are a major problem with severe consequences for socio-economic status and health outcomes. Most of the published evidence to date relates to...
10.
Squire S
BMC Proc
. 2017 Mar;
9(Suppl 10):S2.
PMID: 28281700
The overall aim of the 2014 Consultation is to bring together internal and external partners to help shape the strategic direction for CAHRD over the 10 to 20 year horizon....